COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 2832: Articles 28311-28320  | Next

Epigenetic regulator miRNA pattern differences among SARS-CoV, SARS-CoV-2 and SARS-CoV-2 world-wide isolates delineated the mystery behind the epic pathogenicity and distinct clinical characteristics of pandemic COVID-19
Khan, M. A.-A.-K., Sany, M. R. U., Islam, M. S., Mehebub, M. S., Islam, A. B. M. M. K.
10.1101/2020.05.06.081026 — Posted: 2020-05-08
COVID-19 Scenarios: an interactive tool to explore the spread and associated morbidity and mortality of SARS-CoV-2
Noll, N. B., Askamentov, I., Druelle, V., Badenhorst, A., Jefferies, G., Albert, J., Neher, R.
10.1101/2020.05.05.20091363 — Posted: 2020-05-07
Development of a Multivariate Prediction Network Model for epidemic progression in order to study the effects of lockdown time and coverage on a closed community of non-immune individuals.
Abramov, D. M., Gomes, S. C.
10.1101/2020.05.04.20090712 — Posted: 2020-05-07
COVID-19 DYNAMICS: A HETEROGENEOUS MODEL
Gerasimov, A., Lebedev, G., Lebedev, M., Semenycheva, I.
10.1101/2020.05.04.20090688 — Posted: 2020-05-07
Cooperative virus propagation underlies COVID-19 transmission dynamics
Dai, Z., Locasale, J. W.
10.1101/2020.05.05.20092361 — Posted: 2020-05-07
Projection of COVID-19 Cases and Deaths in the US as Individual States Re-open May 4,2020
Yamana, T., Pei, S., Shaman, J.
10.1101/2020.05.04.20090670 — Posted: 2020-05-07
Urban Air Pollution May Enhance COVID-19 Case-Fatality and Mortality Rates in the United States
Liang, D., Shi, L., Zhao, J., Liu, P., Schwartz, J., Gao, S., Sarnat, J. A., Liu, Y., Ebelt, S. T., Scovronick, N. C., Chang, H.
10.1101/2020.05.04.20090746 — Posted: 2020-05-07
The disproportionate rise in COVID-19 cases among Hispanic/Latinx in disadvantaged communities of Orange County, California: A socioeconomic case-series
Chow, D. S., Soun, J., Gavis-Bloom, J., Weinberg, B., Chang, P., Mutasa, S., Monuki, E., Park, J. I., Xie, X., Bota, D., Wu, J., Thompson, L., Amin, A., Khan, S., Boden-Albala, B.
10.1101/2020.05.04.20090878 — Posted: 2020-05-07 Discussion: Offsite
Scaling COVID-19 against inequalities: should the policy response consistently match the mortality challenge?
McCartney, G., Leyland, A., Walsh, D., Dundas, R.
10.1101/2020.05.04.20090761 — Posted: 2020-05-07
Single-cell longitudinal analysis of SARS-CoV-2 infection in human bronchial epithelial cells
Ravindra, N. G., Alfajaro, M. M., Gasque, V., Wei, J., Filler, R. B., Huston, N. C., Wan, H., Szigeti-Buck, K., Wang, B., Montgomery, R. R., eisenbarth, S. C., Williams, A., Pyle, A. M., Iwasaki, A., Horvath, T. L., Foxman, E. F., van Dijk, D., Wilen, C.
10.1101/2020.05.06.081695 — Posted: 2020-05-07 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).